SCHEMBL8686827

SCHEMBL8686827

O=C1NC(=O)/C(=C/c2cccc3c2ccn3S(=O)(=O)c2ccc(F)cc2)S1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 6/20 0.52
▸ KMT2A Q03164 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ TTR P02766 2/20 0.48
▸ AKR1B1 P15121 1/20 0.48
▸ PIM1 P11309 2/20 0.48
▸ PIM2 Q9P1W9 2/20 0.48
▸ IGF1R P08069 1/20 0.47
▸ HTR6 P50406 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ NAT1 P18440 1/20 0.42
▸ TDP2 O95551 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ CASP9 P55211 1/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ CASP8 Q14790 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808598 1.00 PARP1 (0.52) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8809653 0.90 TTR (0.54) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8685838 0.90 TTR (0.54) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8811258 0.90 MEN1 (0.54) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8685694 0.90 MEN1 (0.54) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8808603 0.88 HTR6 (0.44) PARP1KMT2AMEN1HTR6HDAC3
SCHEMBL8811339 0.86 PARP1 (0.63) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8810481 0.86 PARP1 (0.63) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8808586 0.83 PARP1 (0.54) PARP1KMT2AMEN1TTRAKR1B1
SCHEMBL8808590 0.83 PARP1 (0.54) PARP1KMT2AMEN1TTRAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 — — US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 — — EP disclosed
Send feedback